Invention Application
US20030073645A1 Treatment of diabetes with thiazolidinedione and alpha-glucosidase inhibitor
审中-公开
用噻唑烷二酮和α-葡糖苷酶抑制剂治疗糖尿病
- Patent Title: Treatment of diabetes with thiazolidinedione and alpha-glucosidase inhibitor
- Patent Title (中): 用噻唑烷二酮和α-葡糖苷酶抑制剂治疗糖尿病
-
Application No.: US10290132Application Date: 2002-11-07
-
Publication No.: US20030073645A1Publication Date: 2003-04-17
- Inventor: Stephen Alistair Smith
- Applicant: SmithKline Beecham plc
- Applicant Address: null
- Assignee: SmithKline Beecham plc
- Current Assignee: SmithKline Beecham plc
- Current Assignee Address: null
- Priority: GB9712865.6 19970618; GB9806708.5 19980327
- Main IPC: A61K031/70
- IPC: A61K031/70 ; A61K031/4439
Abstract:
A method for the treatment of diabetes mellitus and conditions associated with diabetes mellitus in a mammal, which method comprises administering an effective non-toxic and pharmaceutically acceptable amount of an insulin sensitiser and an alpha-glucosidase inhibitor antihyperglycaemic agent, to a mammal in need thereof.
Information query
